TrialJournal of the National Cancer Institute2010

Ornithine decarboxylase-1 polymorphism, chemoprevention with eflornithine and sulindac, and outcomes among colorectal adenoma patients.

Jason A Zell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.